Consistent results have also been confirmed the high prevalence of TERT mutation in bladder cancer, Glioma and Melanoma and a lower mutation frequency of breast cancer and prostate cancer, although they occurred with different frequencies [21–25]. This evidence concerns the gene TERT and urinary bladder carcinoma.